Lyra Therapeutics, Inc. — 10-Q Filings
18 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Lyra Therapeutics, Inc. (LYRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lyra Therapeutics, Inc. has filed 18 10-Q documents with the SEC since 2005. To view all SEC filings by Lyra Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
REGDEX
REGDEX/A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-277564 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-107367 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-064495 | May 6, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-125494 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-097042 | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-050535 | Apr 30, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-060298 | Nov 7, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-039830 | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-021497 | May 12, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-023266 | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001564590-22-028609 | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001564590-22-019102 | May 10, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001564590-21-055778 | Nov 9, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-042711 | Aug 9, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-026569 | May 11, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001564590-20-053016 | Nov 10, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-036803 | Aug 5, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-027334 | May 28, 2020 | Mar 31, 2020 |